Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,582 | Dovepress* | 6,522+ | 371 | 6,893 | |
PubMed Central* | 3,060 | 355 | 3,415 | ||
Totals | 9,582 | 726 | 10,308 | ||
*Since 23 June 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed and Google Scholar